ZMIZ1 and nonpapillary renal cell carcinoma: In addition, the ceRNA network of the SNHG17/PVT1/ZMIZ1-AS1-miR-23b-3p-SGOL1 axis might offer novel perspectives for the immunotherapy of ccRCC patients.